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Abstract
Platelet-derived microparticles (PMP) bind and modify the phenotype of many cell types including endothelial cells. Recently, we showed
that PMP were internalized by human brain endothelial cells (HBEC). Here we intend to better characterize the internalization mechanisms
of PMP and their intracellular fate. Confocal microscopy analysis of PKH67-labelled PMP distribution in HBEC showed PMP in early endo-
some antigen 1 positive endosomes and in LysoTracker-labelled lysosomes, confirming a role for endocytosis in PMP  internalization. No
fusion of calcein-loaded PMP with HBEC membranes was observed. Quantification of PMP endocytosis using flow cytometry revealed
that it was partially inhibited by trypsin digestion of PMP surface proteins and by extracellular Ca2 chelation by EDTA, suggesting a  
partial role for receptor-mediated endocytosis in PMP uptake. This endocytosis was independent of endothelial receptors such as inter-
cellular adhesion molecule-1 and vascular cell adhesion molecule-1 and was not increased by tumour necrosis factor stimulation of HBEC.
Platelet-derived microparticle  internalization was dramatically increased in the presence of decomplemented serum, suggesting a role for
PMP opsonin-dependent phagocytosis. Platelet-derived microparticle uptake was greatly diminished by treatment of HBEC with cytocha-
lasin D, an inhibitor of microfilament formation required for both phagocytosis and macropinocytosis, with methyl--cyclodextrin that
depletes membrane cholesterol needed for macropinocytosis and with amiloride that inhibits the Na/H exchanger involved in
macropinocytosis. In conclusion, PMP are taken up by active endocytosis in HBEC, involving mechanisms consistent with both phagocy-
tosis and macropinocytosis. These findings identify new processes by which PMP could modify endothelial cell phenotype and functions.
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Introduction
Microparticles (MP) are submicron membrane fragments released
from many cell types upon activation or apoptosis. Their compo-
sition and functional properties vary with their cellular origin and
the type of stimulus involved in their formation. Circulating MP
mainly derive from platelets. Elevated levels of PMP have been
associated with numerous pathological states such as
atherothrombosis [1] or infectious diseases [2, 3]. Platelet-
derived microparticle interactions with various cell types and their
functional consequences have been described in many studies.
Indeed, PMP modulate biological functions of endothelial cells,
leucocytes or haematopoietic cells via antigens, bioactive lipids or
chemokines that they transport [4–11].
Less attention has been paid to the fate of PMP and neither
their life span nor the mechanisms of their clearance have been
clearly determined yet. Several groups suggested that PMP were
cleared from the circulation very quickly following infusion into
animal [12, 13] and, more recently, lactadherin has been identified
as one of the mediators of the clearance of phosphatidylserine
(PS)-expressing PMP by splenic macrophages [14].
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In a recent study, we showed that PMP were internalized by
HBEC by an active process and induced changes in the surface
phenotype of these cells that could have a pivotal role in the patho-
genesis of cerebral malaria, an acute encephalopathy  secondary to
the infection by Plasmodium falciparum [15]. However, this inter-
nalization process had not been characterized. Here, using fluores-
cent markers for several endocytic compartments and various
specific endocytosis inhibitors, we further characterize the intra-
cellular sorting of PMP in HBEC and the mechanisms involved in
this endocytosis. These analyses may help not only to elucidate
the mechanisms by which PMP are taken up and degraded or
recycled by cells, but also provide new insights in the regulation
of the transport of biomolecules by PMP into target cells.
Materials and methods
Microvascular endothelial cells
Human brain endothelial cells, HBEC-5i, were derived by Dorovini-Zis 
et al. from small fragments of human cerebral cortex obtained from
patients who had died of various causes [16]. These immortalized cells
were then characterized and maintained in our laboratory, as described
elsewhere [15, 17].
Platelet microparticles
Platelet-derived microparticles were purified from in vitro-activated platelet
supernatants and labelled with red PKH26 or green PKH67 (Sigma-Aldrich,
St. Louis, MO, USA) as previously described [15]. Briefly, washed platelets
from human blood were incubated for 45 min. at 37C in the presence 
of calcium ionophore A23187 (10 mol/l). Platelets and cell debris 
were removed by serial centrifugations (6 min. at 2000  g and 2 min. at
13,000  g), PMP were pelleted by centrifugation 60 min. at 20,800  g
and resuspended in PBS. Platelet-derived microparticles were then mixed
volume to volume with PKH by gentle pipetting for 1 min. and washed with
DMEM without phenol red (Gibco-Invitrogen-Life Technologies, Villebon
sur Yvette, France). Alternatively, PMP were directly incubated with 
10 g/ml calcein AM (Invitrogen, Marseille, France) for 60 min. at 37C
and washed twice in PBS. Labelled PMP were counted by flow cytometry.
Supernatants resulting from the final wash were used as a control.
In some experiments, to remove protease-sensitive glycoproteins from
the surface of PMP, we performed digestion by 0.25% (w/v) trypsin
(Gibco) for 30 min. at 37C as described by Baj-Krzyworzeka et al. [18].
Identification of the endocytic compartments
 containing PMP
Human brain endothelial cells grown to confluence on gelatin-coated 8-well
labtek slides (Nunc) were incubated for 90 min. total incubation time at 37C
with PKH67-labelled PMP and washed to remove unbound PMP. LysoTracker
Red DND-99 (50 nM; Invitrogen) or ER-Tracker Red (100 nM; Invitrogen),
for the labelling of lysosomes or endoplasmic reticulum respectively, were
added 30 min. before washing and fixation. For early endosome labelling,
HBEC were fixed with 4% (v/v) paraformaldehyde for 10 min. and permeabi-
lized with Triton X-100 0.1% (v/v) in PBS 5 min. at room temperature. Non-
specific binding was blocked by incubation for 30 min. in PBS containing 1%
(w/v) BSA. Early endosome antigen 1 (EEA-1) was detected using a mouse
monoclonal IgG1 to EEA-1 (clone 14, 1:1000; BD Transduction Laboratories,
San Jose, CA, USA) revealed with Alexa-Fluor 555 conjugated goat anti-
mouse secondary antibody (1:400; Invitrogen). Both primary and secondary
antibodies were diluted in 1% (w/v) BSA in PBS and incubated for 1 hr at
room temperature. Finally, cells were washed and kept in PBS for analysis.
Samples were analysed by  confocal laser scanning microscopy using an
Axiovert 200 inverted microscope, equipped with a Zeiss LSM 510 scanning
module and Zeiss LSM510 Software (Zeiss, Oberkochen, Germany).
PMP endocytosis by HBEC and inhibition assays
To quantify PMP endocytosis by HBEC, cells were grown to confluence in
96-well plates and were either left unstimulated or incubated overnight
with 10 ng/ml tumour necrosis factor (TNF). Cell monolayers were then
washed in serum-free medium and further incubated for 90 min. at 37C
with PKH67-labelled PMP (2000/l) in serum-free DMEM.
To evaluate the effect of serum in PMP endocytosis, medium was sup-
plemented with 10% foetal calf serum (FCS; Gibco) decomplemented by
heating for 30 min. at 56C.
In some experiments, the calcium-chelator EDTA was added to the
medium to a final concentration of 2.5 mM during endocytosis assay to
investigate the role of extracellular calcium in PMP endocytosis.
To evaluate the role of endothelial surface adhesion receptors in PMP
internalization, HBEC were first pre-incubated for 30 min. at 4C with mAbs
against vascular cell adhesion molecule-1 (VCAM-1, CD106, clone 1G11,
IgG1) and intercellular adhesion molecule-1 (ICAM-1, CD54, clone 84H10,
IgG1) purchased from Beckman Coulter Immunotech. An irrelevant iso-
type-matched mAb (clone 679.1Mc7) was used as control.
To evaluate the effects of specific endocytosis inhibitors, HBEC were
first pre-incubated with the following inhibitors in serum-free medium for
30 min. at 37C: 10 M cytochalasin D, 10 mM methyl--cyclodextrin and
250 M amiloride. Cytochalasin D and amiloride were kept in the medium
during the endocytosis assay. To avoid any effect of cholesterol depletion
on PMP integrity, a washing step to remove methyl--cyclodextrin from
the prior co-incubation medium was necessary before the addition of PMP
and the endocytosis assay was carried out in the absence of this inhibitor.
Cells were incubated with 0.5 mg/ml 70 kD-dextran (Sigma-Aldrich) at
37C for 30 min. as a positive control for macropinocytosis.
Each inhibitor and EDTA were tested at different concentrations to
establish working concentrations for maximum inhibition without toxic
effects on cells. After incubation, HBEC were washed, detached by a short
trypsin treatment and analysed for fluorescence by flow cytometry. To
assess effective activation of HBEC by TNF, detached HBEC were analysed
for surface up-regulation of VCAM-1 and ICAM-1 by flow cytometry as
 previously described [17]. For all these experimental conditions, flow
cytometry analyses were performed with live cells using an Epics XL flow
cytometer (Beckman Coulter Immunotech). Data were obtained and
analysed using System2 software (Beckman Coulter Immunotech). Live
cells were gated by forward/side scattering from a total of 10,000 events.
Statistical analyses
Continuous variables were tested for normal distribution with the
Kolmogorov–Smirnov test and are presented as continuous variables as
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mean  S.D. Means between two groups were compared using a two-
tailed unpaired Student’s t-test. P values less than 0.05 were accepted as
significant. All statistical analyses were performed with GraphPad Prism
version 4.0 for Windows Software.
Results
Subcellular localization of internalized PMP
We previously demonstrated that PMP were internalized by HBEC
in a time-dependent and temperature-sensitive process [15]. Once
internalized, PMP were found to be surrounded by membranes
labelled with Alexa-555 coupled wheat germ agglutinin, suggest-
ing that PMP moved into large intracellular vesicles but did not
stay along the plasma membrane.
To evaluate the potential role of endocytosis in PMP uptake, we
first identified the intracellular vesicles in which PMP were
processed after internalization. Using confocal microscopy, the
cell distribution of PHK67-labelled PMP was compared to that of
endosomal structures, as revealed by EEA1 and LysoTracker red
staining. As shown in Figure 1, after 90 min. of co-incubation,
15% of PMP were found in EEA1-positive vesicles (top) and most
PMP co-localized with LysoTracker red fluorescence in HBEC
(middle). These data clearly indicate that PMP are internalized by
an endocytic process and that, after uptake, PMP traffic along the
endosomal compartment through early endosomes towards more
acidic lysosomes. Endocytosed PMP showed no colocalization
Fig. 1 PMP are present in early endosomes and lysosomes. HBEC were incubated with PKH67-labelled PMP (green) or with PMP supernatants as a neg-
ative control for 90 min. at 37C. HBEC were labelled with mouse anti-EEA-1 IgG revealed with Alexa 555-coupled goat antimouse IgG (top, red), with
LysoTracker (middle, red) or with ER-Tracker (bottom, red). Cells were then analysed by confocal microscopy. For each selected sample, 15 optical sec-
tions separated by 0.6 nm steps were analysed. The lens used was a Zeiss Plan-Apochromat 63/1.40 oil immersion objective lens. Inserts of the merged
images are represented in the right column. Bars: 10 m.
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with ER-Tracker staining (bottom), indicating that endocytosed
PMP did not enter the retrograde-transport pathway to the endo-
plasmic reticulum at that time.
Detection of PMP fusion with HBEC membrane by
calcein release
To search for PMP fusion with the endothelial membrane and to
detect a possible PMP fragmentation once internalized, PMP con-
tent was stained with soluble calcein AM (green) in addition to the
membranous PKH26-labelling (red). After staining, 48% of PMP
were double labelled for both calcein and PKH26 (Fig. 2A). Figure
2B shows that, after PMP internalization by HBEC, no PKH26 was
transferred from PMP to endothelial membrane and no entrapped
calcein was released within the cytosol, suggesting that PMP
content did not diffuse inside the target cell but remained co-
localized with PMP membranes. This observation clearly indi-
cates that PMP internalization by HBEC does not involve the
fusion of PMP lipids with the endothelial plasma membrane but,
rather, an uptake of PMP material with subsequent localization in
intracellular vesicles.
Mechanisms of PMP endocytosis
To further characterize PMP internalization by HBEC, we tested the
effect of different modulators added just before or during the inter-
nalization assay and quantified the uptake of PKH67-labelled PMP
by flow cytometry (Fig. 3A). Firstly, PMP internalization was only
reduced by 38% after trypsin digestion (Fig. 3B), indicating that,
in addition to the trypsin-sensitive protein components of PMP,
other trypsin-resistant components such as lipids can be respon-
sible for their interaction with HBEC. Secondly, pre-treatment of
HBEC with EDTA resulted in a significant 33% decrease of PMP
uptake (Fig. 3B), suggesting that this phenomenon is partially cal-
cium dependent. Thirdly, we showed that PMP internalization was
not affected when HBEC were first incubated with mAbs against
VCAM-1 or ICAM-1. Moreover, PMP internalization was not
increased in TNF-pre-stimulated HBEC as compared to resting
cells (Fig. 3B). This suggests that PMP internalization is not medi-
ated by TNF-up-regulated adhesion receptors such as VCAM-1 or
ICAM-1. Surprisingly, in the presence of decomplemented FCS,
there was a threefold increase in PMP uptake (Fig. 3B), suggest-
ing a role for PMP opsonization by decomplemented FCS in their
entry into HBEC.
To determine which of the several possible cellular uptake
mechanisms were responsible for PMP internalization, the effects
of three different endocytosis inhibitors were examined. These
inhibitors were also tested on the entry of 70-kD FITC-dextran, a
marker of macropinocytosis, for comparison. Cytochalasin D was
used to inhibit actin elongation and the formation of microfila-
ments and microtubules, methyl--cyclodextrin to deplete mem-
brane cholesterol and inhibit lipid raft-dependent pathways, and
amiloride was tested to inhibit the Na/H exchanger required for
macropinocytosis [19]. In HBEC, 70 kD FITC-dextran endocytosis
was reduced by methyl--cyclodextrin and amiloride, as expected
for macropinocytosis (Fig. 3C, grey bars). Cytochalasin D was
found to produce an unexpected increase in dextran entry into
HBEC, indicating an alteration in macropinocytosis with this
inhibitor. In contrast, all drugs tested were found to partially inhibit
the entry of PMP into HBEC (Fig. 3C, black bars).
Discussion
A growing number of studies report the cellular uptake of MP by
mononuclear haematopoietic cells, monocytes, neutrophils, plas-
macytoid dendritic cells [18, 20–23] and by endothelial cells [15,
24–26]. However, the mechanisms involved in this process have
not been clearly defined yet.
Fig. 2 Co-localization of PMP cytoplasmic content and PMP-derived membranes inside the target cell. PMP were double-labelled with membrane dye
PKH26 (red) and calcein AM that only becomes green fluorescent once hydrolysed by cytoplasmic esterases. (A) Analysis of PMP double-labelling by
flow cytometry. Number in the upper right quadrant represents the percentage of double-labelled PMP. (B) PMP were then incubated with HBEC for 
90 min. at 37C. PMP supernatant was used as a negative control. Cells were washed, fixed with PFA 2% (v/v) and analysed by confocal microscopy. Merged
images showing transmitted light and green and red channels are represented. Insert of the merged image is represented in the right column. Bar: 10 m.
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In this study, we have examined the intracellular localization of
PMP internalized by brain microvascular endothelial cells and
attempted to decipher the pathways involved in this phenomenon.
Using markers for endosomal compartments, we demonstrated
for the first time that internalized PMP were distributed within
endosomes and lysosomes after cell entry, supporting the fact that
endocytosis was the predominant route of PMP entry into
endothelial cells. This major finding differs from the recent work
by Terrisse et al. who did not find any co-localization of endocy-
tosed endothelial-derived MP with markers of early or late endo-
somes after 2 hrs of co-incubation with HUVEC [25], suggesting
that either kinetics or pathways for MP intracellular processing
might vary between different endothelial cell types.
Although PMP were efficiently endocytosed by endothelial
cells, they did not fuse with their plasma membrane because no
diffusion of calcein-labelled PMP content occurred inside the tar-
get cell cytosol. This is consistent with the observation of Aharon
et al. who found that monocyte-derived MP bound to and were
ingested by HUVEC without any fusion of MP with the cell mem-
brane [24] but contrasts with the fusion of monocyte-derived MP
with activated platelets described by del Conde et al. [27]. These
results suggest that MP interaction might involve different mech-
anisms depending on the target cell type.
Endocytosis may occur through several distinct mecha-
nisms, usually divided into two broad categories: phagocytosis,
a process restricted to specialized mammalian cells, and
pinocytosis, which occurs in all mammalian cells and encom-
passes macropinocytosis, clathrin-mediated endocytosis, and
caveolae-mediated endocytosis [28]. Although clathrin- and
caveolin-dependent endocytosis involve the uptake of particles
smaller than 100 nm in diameter, phagocytosis and
macropinocytosis involve the uptake of larger volumes.
Because MP are defined as particles with a diameter varying
between 100 and 1000 nm [6], we focused on the potential role
for phagocytosis or macropinocytosis in PMP uptake.
Although phagocytosis requires cell-surface recognition of
particles and proceeds via sequential engagement of receptors,
macropinocytosis occurs via non-selective membrane uptake. We
thus tried to determine which type of MP surface components
and endothelial receptors could be involved in MP endocytosis by
HBEC. The partial inhibition of PMP internalization after treatment
of PMP with trypsin indicates that protease-sensitive compo-
nents of PMP, such as surface glycoproteins, play a minor role in
PMP binding and further internalization but rather supports a role
for other components such as lipids. PMP uptake was slightly
inhibited by EDTA, suggesting that Ca2-dependent (usually
Fig. 3 PMP endocytosis assay. HBEC were
incubated with PKH67-labelled PMP or 70
kD FITC-dextran for 90 min. at 37C. PMP
supernatant was the negative control.
Fluorescent cells were quantified by flow
cytometry. (A) Numbers in the upper right
quadrants represent the percentage of fluo-
rescent cells. (B) HBEC were either co-incu-
bated with trypsin-treated PMP, co-incu-
bated with PMP in the presence of EDTA,
pre-incubated with blocking mAbs against
ICAM-1 or VCAM-1, pre-stimulated with
TNF before PMP co-incubation or co-incu-
bated with PMP in the presence of decom-
plemented FCS. (C) Effects of specific
endocytosis inhibitors on PMP or 70 kD
FITC-dextran uptake. HBEC were pre-
treated with cytochalasin D, methyl--
cyclodextrin or amiloride for 30 min. prior
to adding PKH67-labelled PMP for 90 min.
or 70 kD FITC-dextran for 30 min. (B, C)
Results are presented as the percentage of
PMP uptake (mean fluorescence intensity)
compared to the 37C-positive control
(mean  S.D.). A two-tailed, unpaired
Student’s t-test was used for comparison of
means; *P  0.05, **P  0.01 and ***P
 0.001.
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receptor-mediated) endocytosis was partly involved in PMP
uptake. Because platelet adhesion and fusion to TNF-activated
brain endothelial cells depends on ICAM-1 up-regulation on
endothelial membranes and LFA-1 expression on platelets
[29–31], we wanted to evaluate the role of ICAM-1 in PMP bind-
ing and internalization by HBEC. Pre-incubation of HBEC with
mAb against ICAM-1 or VCAM-1 failed to inhibit PMP uptake.
Furthermore, TNF activation of HBEC, which increases both
ICAM-1 or VCAM-1 expression on HBEC surface [17], did not
increase PMP internalization, implying that these adhesion recep-
tors are not required for PMP endocytosis. On the other hand, the
increased uptake of PMP in the presence of decomplemented FCS
suggests that PMP can be opsonized by FCS components other
than proteins from the complement cascade supporting a role for
phagocytosis.
The composition of MP is related to their cellular origin and
to the type of stimulus involved in their formation; therefore, the
cellular events required for their internalization may differ
between both target cells and MP cellular origins. Nonetheless,
one common feature of MP is the exposure on their external
leaflet of PS, also present on the external surface of apoptotic
cells and apoptotic platelets. PS exposure [32, 33] and recogni-
tion by many receptors such as scavenger receptors present on
macrophages [34] are crucial for phagocytosis and clearance of
apoptotic platelets and are probably also relevant in the clear-
ance of PMP. Indeed, three recent studies showed that MP
endocytosis by either HUVEC [25, 26] or macrophages [35] was
significantly inhibited in the presence of annexin V suggesting a
major role for PS. Flaumenhaft proposed that PS exposure on
PMP may support opsonization by C3b. C3b-bearing PMP could
subsequently bind to erythrocytes through complement recep-
tor CR1 and be delivered to scavenger endothelium in the liver
and spleen by receptor-mediated endocytosis [13]. Scavenger
receptors have been evoked to be involved in the removal from
the circulation of red blood cell-derived MP by Kupffer cells in
the liver [36]. Both scavenger receptors [37, 38] and PS recep-
tor (PSR) [39] are expressed on microvascular endothelial cells
but PSR is highly unlikely to be involved in PMP endocytosis
under basal conditions because PSR does not appear to be con-
stitutively expressed on the cell surface [39]. Other opsonins
such as 2-glycoprotein I [35], IgM [40] or lactadherin [14]
have been involved in MP phagocytosis by macrophages.
Recently, Terrisse et al. showed that HUVEC internalized
endothelium-derived MP through a process involving anionic
phospholipids, lactadherin and 	v3 integrin but not CD36
[25]. The importance of this potential interaction in our experi-
mental model warrants further investigations especially as
HBEC-5i express constitutive 	v3 integrin but no CD36 on
their surface [17].
Both phagocytosis and micropinocytosis are characterized by
extensive membrane reorganization and are reduced by cytocha-
lasin D treatment [28]. Thus, the reduction of PMP entry into
cells by cytochalasin D does not allow us to identify one of the
two processes as a major pathway for PMP entry into HBEC. The
decrease of PMP uptake by the cholesterol depleting agent
methyl--cyclodextrin shows that PMP endocytosis depends on
cholesterol content and suggests a role for macropinocytosis
because cholesterol is required for membrane ruffling and
macropinocytosis [41]. It should be stressed out that, in addition
to cholesterol depletion, methyl--cyclodextrin has pleiotropic
effects on different membrane components, such as phospho-
lipids, that could have a potential role in PMP endocytosis. The
incomplete inhibition of PMP entry by the Na/K transporter
inhibitor amiloride indicates that endocytic uptake of PMP
occurs partially by non-selective macropinocytosis [19]. The
unique susceptibility of macropinocytosis to inhibitors of
Na/H exchange has been extensively used to differentiate it
from other types of endocytosis. However, caution should be
made in interpreting these data because the inhibition of
macropinocytosis by amiloride could also result from its effects
on cell pH [42].
Phagocytosis of particles, apoptotic bodies and aged erythro-
cytes is predominately attributed to macrophages, neutrophils and
dendritic cells. However, several studies have described the uptake
of large objects by endothelial cells, including apoptotic bodies
[43–46] and MP [24–26]. More surprising is the endocytic activ-
ity of endothelial cells derived from the brain. Indeed, the most
important function of endothelial cells that line the brain capillar-
ies is to form the blood–brain barrier (BBB), which physically sep-
arates blood components from the brain and the cerebrospinal
fluid. This barrier is based, in part, on a paucity of vesicular activ-
ity within the brain microvascular endothelial cells that limits
endocytosis. However, endocytosis can be modulated by vasoac-
tive substances, such as angiotensin and bradykinin [47], and
cytokines, such as TNF [48], and may dramatically increase in dis-
ease states, rendering the BBB less restrictive for blood-borne
proteins and cells.
Understanding PMP endocytotic process could provide essen-
tial clues that may reveal how endothelial cells can differentially
regulate the transport of different components across the BBB.
This is likely to shed light on the processes underlying numerous
neurological disorders during which an increased production of
PMP at the interface of the BBB occurs. For example, PMP carry
agents implicated in neurodegenerative disorders such as amyloid
-protein precursor present in amyloid plaques in Alzheimer’s dis-
ease [49] and PMP could actively transport these agents across
the BBB [50].
Overall, our findings provide new mechanisms by which 
MP interact with endothelial cells and could modify their phe-
notype and functions. This could help understand the role of
MP in the broad range of physiological and pathological
processes during which MP levels are increased. MP uptake by
endothelial cells could also participate in MP clearance from
the circulation.
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